ELAN

Over the past six months, Elanco Animal Health's stock price has seen a positive trend, with a 9.56% increase as of May 6, 2026, and shares have risen approximately 163% over the past year. Key events impacting the stock include strong Q1 2026 results with revenue increasing 15% year-over-year, raised full-year 2026 revenue estimate and adjusted EPS guidance, strong performance of new products like Zenrelia and Credelio Quattro, a restructuring plan aimed at margin expansion and optimizing its footprint, and the acquisition of the AHV farm animal business.